The National Institutes of Health established a research network to test the effectiveness of community-based harm reduction strategies to curb drug overdoses and deaths. Efforts build on existing harm reduction research and represent the largest pool of funding from NIH to date to study these strategies.   

“Getting people into treatment for substance use disorders is critical, but first, people need to survive to have that choice,” said Nora D. Volkow, M.D., director of the National Institute on Drug Abuse. “Harm reduction services acknowledge this reality by aiming to meet people where they are to improve health, prevent overdoses, save lives and provide treatment options to individuals. Research to better understand how different harm reduction models may work in communities across the country is therefore crucial to address the overdose crisis strategically and effectively.” 

The network — comprised of nine research projects and one coordinating center — will also examine the efficacy of moving harm reduction services into communities via mobile vans, peer support specialists, digital tools and other outreach. 

Related News Articles

Headline
AHA podcast: Food as Medicine — How Cleveland Clinic Is Nourishing Community HealthVickie Johnson, executive vice president and chief community officer at…
Headline
As part of Community Health Improvement Week June 9-13, two experts from Corewell Health share how an impactful health care ecosystem model is supporting local…
Headline
With June 9-13 being Community Health Improvement Week, three experts from HonorHealth discuss how the health care network is addressing community needs beyond…
Blog
Even before the COVID pandemic, the mental health and wellness of our young people was failing. The pandemic exacerbated the crisis and made it difficult for…
Headline
A new AHA video highlights how Corewell Health is transforming youth behavioral health care access in rural Michigan through school-based clinics and…
Headline
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer’s disease. The test, created by Fujirebio Diagnostics,…